An ongoing legal battle between a pair of competing real estate listing firms has heated up with Blue Springs company Xceligent accusing rival CoStar of anti-competitive business practices.
CoStar and Xceligent are multisided platforms that serve the commercial real estate industry similarly to how Zillow and Trulia do for home buyers and sellers: Both research and publish online databases of commercial, retail and industrial buildings. The listings include information such as overall building square footage, market value and occupancy rates. The databases are relied upon by real estate brokers, appraisers and others in the commercial real estate business.
Both companies populate their databases by calling building owners, real estate brokers and tenants to obtain information about the listings.
CoStar, a publicly traded company based in Washington, is by far the leader in the commercial real estate listings business. Xceligent claims CoStar tried to keep its distance ahead of competitors by insisting to its broker and property owner contacts that they could not share their information with other listing firms.
Xceligent also accused CoStar of falsifying information in its own databases without notifying brokers and property owners who provided the data.
Full Content: BISNOW
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan